Literature DB >> 31079346

Cognitive Impairments in First-Episode Drug-Naïve Versus Medicated Depressive Patients: RBANS in a Chinese Population.

Qiu Fang Jia1, Peng Chen1, Hong Liang Zhu1, Shan Shan Chen1, Xiao Chu Gu1, Xu Yuan Yin1, Yan Hai Wu2, Guang Zhong Yin1, Li Hui3,4.   

Abstract

Cognitive deficits are a core feature of major depressive disorder (MDD). However, there are no previous studies that directly compare cognitive performance between first-episode drug-naive depressive patients (FDDP) and medicated depressive patients (MDP). Therefore, the aim of this study was to investigate whether there were the differences in cognitive functions between FDDP and MDP. Sixty-two FDDP, 111 MDP and 90 healthy controls were enrolled in a Chinese population. Cognitive functions were assessed using the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). There were the differences in the RBANS total score (F = 26.55, p < 0.001), subscales of immediate memory (F = 3.95, p = 0.02), language (F = 54.11, p < 0.001) and delayed memory (F = 11.19, p = 0.001) among the three groups after controlling for gender, education, smoking and body mass index (BMI). These differences in the RBANS total score, subscales of language and delayed memory passed the Bonferroni corrections (all, p < 0.05). Compared to healthy controls, FDDP and MDP had poorer cognitive performance including the RBANS total score, and subscales of language and delayed memory (all, p < 0.05) after controlling for the variables. FDDP experienced greater language deficits than MDP (p < 0.05) after controlling for the variables. Education was correlated with the language score in FDDP (r = 0.61, p < 0.001). Multivariate regression analysis indicated that education was an independent contributor to the language score in FDDP (ß = 3.11, t = 5.48, p < 0.001). Our findings indicated that FDDP had poorer language performance than MDP. Moreover, education could influence the language performance in FDDP.

Entities:  

Keywords:  Cognitive impairments; Correlation; Depressive patients; Education

Mesh:

Year:  2019        PMID: 31079346     DOI: 10.1007/s11126-019-09641-4

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  44 in total

1.  Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task.

Authors:  M R Basso; R A Bornstein
Journal:  Neuropsychology       Date:  1999-10       Impact factor: 3.295

2.  The modulation of venlafaxine on cortical activation of language area in healthy subjects with fMRI study.

Authors:  Qi Xie; Yan Liu; Chun-Yong Li; Xue-Zhu Song; Jun Wang; Li-Xin Han; Hong-Min Bai
Journal:  Psychopharmacology (Berl)       Date:  2012-05-04       Impact factor: 4.530

Review 3.  Pharmacotherapy for recovery of function after brain injury.

Authors:  D M Feeney; R L Sutton
Journal:  Crit Rev Neurobiol       Date:  1987

4.  Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder.

Authors:  Tian Nan Shao; Guang Zhong Yin; Xiao Li Yin; Jing Qin Wu; Xiang Dong Du; Hong Liang Zhu; Jia Hong Liu; Xiao Qiong Wang; Dong Wu Xu; Wen Jie Tang; Li Hui
Journal:  Compr Psychiatry       Date:  2017-03-14       Impact factor: 3.735

5.  Examining the association between late-life depressive symptoms, cognitive function, and brain volumes in the context of cognitive reserve.

Authors:  Deirdre M O'Shea; Robert A Fieo; Jamie L Hamilton; Laura B Zahodne; Jennifer J Manly; Yaakov Stern
Journal:  Int J Geriatr Psychiatry       Date:  2014-08-22       Impact factor: 3.485

6.  Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysis.

Authors:  Meghan B Mitchell; Lynn W Shaughnessy; Steven D Shirk; Frances M Yang; Alireza Atri
Journal:  J Int Neuropsychol Soc       Date:  2012-10-08       Impact factor: 2.892

7.  Cognitive functions in depressive disorders: evidence from a population-based study.

Authors:  E Airaksinen; M Larsson; I Lundberg; Y Forsell
Journal:  Psychol Med       Date:  2004-01       Impact factor: 7.723

8.  BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Stuart Maudsley; Bronwen Martin
Journal:  Trends Neurosci       Date:  2004-10       Impact factor: 13.837

Review 9.  Cognitive impairment in depression: a systematic review and meta-analysis.

Authors:  P L Rock; J P Roiser; W J Riedel; A D Blackwell
Journal:  Psychol Med       Date:  2013-10-29       Impact factor: 7.723

10.  Emotion, working memory, and cognitive control in patients with first-onset and previously untreated minor depressive disorders.

Authors:  Mi Li; Shengfu Lu; Gang Wang; Lei Feng; Bingbing Fu; Ning Zhong
Journal:  J Int Med Res       Date:  2016-04-18       Impact factor: 1.671

View more
  1 in total

Review 1.  Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state.

Authors:  Dominik Kriesche; Christian F J Woll; Nadja Tschentscher; Rolf R Engel; Susanne Karch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-01       Impact factor: 5.760

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.